Cafepharma Today

June 5 2025 - GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
Bispecific cancer drugs, data caveats and funding alarms: 3 takeaways from ASCO
FDA’s Elsa AI is here, and the industry has questions
Merck gains U.S. patent office support in Keytruda dispute
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Procysbi (Raptor Pharmaceuticals): A Long Acting Cysteine For The Treatment Of Cystinosis
Seeking Alpha
Wednesday, March 27, 2013 - 9:56am
tags:
Raptor Pharmaceuticals, procysbi, cystinosis
Is Merck's Type 2 Diabetes Blockbuster in Trouble?
Motley Fool
Wednesday, March 27, 2013 - 9:54am
tags:
Merck, Januvia, diabetes
Alzheimer's Drug Race Heats Up With Lundbeck Deal
Investors.com
Wednesday, March 27, 2013 - 9:52am
tags:
Lundbeck, Alzheimer's disease, Otsuka, Lu AE58054
Is Acadia An Acquisition Target?
Seeking Alpha
Wednesday, March 27, 2013 - 9:50am
tags:
Acadia, M&A, AstraZeneca
Johnson & Johnson's OneTouch Proves Not All Recalls Are Alike
Motley Fool
Tuesday, March 26, 2013 - 10:50am
tags:
recalls, LifeScan, JNJ, blood glucose monitoring
Trius targets key approvals after antibiotic matches Zyvox (again) in Phase III
Fierce Biotech
Tuesday, March 26, 2013 - 10:41am
tags:
Trius, antiobiotics, Zyvox, tedizolid
Will Dendreon Continue to Plummet?
Wall St. Cheat Sheet
Tuesday, March 26, 2013 - 10:38am
tags:
Dendreon, Provenge
Halozyme Rallies On Success In Europe, US Next Target
Seeking Alpha
Tuesday, March 26, 2013 - 10:38am
tags:
Halozyme, Europe, Baxter International, HyQvia
Acceleron Receives Two FDA Orphan Designations for ACE-536
Yahoo
Tuesday, March 26, 2013 - 10:34am
tags:
FDA, orphan drugs, ACE-536, Acceleron, beta-thalassemia, myelodysplastic syndromes
Ziopharm cancer drug fails in late-stage trial; shares plunge
Reuters
Tuesday, March 26, 2013 - 10:31am
tags:
Ziopharm, palifosfamide, soft tissue sarcomas
Pipeline Setback at BioLineRx
Yahoo/Zacks
Tuesday, March 26, 2013 - 10:30am
tags:
BioLineRx, BL-1020, schizophrenia
Savient Pharmaceuticals: Is Anything Left?
Seeking Alpha
Tuesday, March 26, 2013 - 10:29am
tags:
Krystexxa, Savient, gout
Idenix Pharma shares sink after regulators determine competitor filed drug patent first
Yahoo/AP
Tuesday, March 26, 2013 - 10:28am
tags:
Gilead Pharmasset, patents, Idenix
Shares of Acadia Pharma jump on confidence a top drug candidate will be approved
Yahoo/AP
Tuesday, March 26, 2013 - 10:27am
tags:
Acadia, pimavanserin, Parkinson's Disease Psychosis
Biogen And The Progress In Multiple Sclerosis Treatment
Seeking Alpha
Tuesday, March 26, 2013 - 10:26am
tags:
MS, multiple sclerosis, Biogen Idec, Tecfidera, BG-12
New Legislation Proposes to Limit Approved Uses for Controlled Release Oxycodone-Hydrochloride for Relief of “Severe-Only” Pain
FDA Law Blog
Tuesday, March 26, 2013 - 10:23am
tags:
oxycontin
Feuerstein: Amarin's Sloooow Vascepa Launch
TheStreet.com
Tuesday, March 26, 2013 - 10:20am
tags:
Amarin, Vascepa, drug launches
Phytopharm gives up after Parkinson's drug failure
Reuters
Tuesday, March 26, 2013 - 10:19am
tags:
Parkinson's Disease, Phytopharm, Cogane
Shire to Buy Eye-Drug Maker SARcode for $160 Million
Bloomberg
Tuesday, March 26, 2013 - 10:18am
tags:
SARcode, M&A, Shire
Pfizer's drug to treat tuberculosis in short supply
Reuters
Tuesday, March 26, 2013 - 10:17am
tags:
Pfizer, tuberculosis, drug shortages, Rifampin

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.